Drugs / LY01015
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06022861 | Oct 2023 → Jun 2025 overdue | esophageal squamous cell carcinoma | Shandong Boan Biotechnology Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY01015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06022861 ↗ |